FDA Adverse Event Injury Summary report: N

ACCU-CHEK ADVANTAGE TEST STRIPS

MDR report key: 732568 · Received July 6, 2006

Report

Report Number
1823260-2006-03394
Event Type
Injury
Date Received
July 6, 2006
Date of Event
January 1, 2004
Report Date
June 7, 2006
Manufacturer
ROCHE DIAGNOSTICS
Product Code
NBW
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MD, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

THIS EVENT WAS DESCRIBED IN A JOURNAL ARTICLE, ENTITLED "INTRAGAM CAN INTERFERE WITH BLOOD GLUCOSE MONITORING," PUBLISHED IN THE MEDICAL JOURNAL OF AUSTRALIA (MJA 2004; 180(5): 251-252). THIS ARTICLE WAS FORWARDED TO MANUFACTURER BY THE FOOD AND DRUG ADMINISTRATION ON 06/07/2006.

Description of Event or Problem · 1

WHILE RECEIVING AN INTRAVENOUS INFUSION OF A HUMAN NORMAL IMMUNOGLOBULIN (CONTAINING 10% MALTOSE - A LABELED INTERFERENT FOR THE TEST STRIPS), A PATIENT'S CAPILLARY BLOOD GLUCOSE WAS MEASURED, USING THE SUSPECT DEVICE, WITH A RESULT OF 9.3 MMOL/L. AT THE SAME TIME, PATIENT'S PLASMA BLOOD GLUCOSE MEASURED 2.3 MMOL/L ON A HOSPITAL DEVICE (TYPE NOT PROVIDED). AN ADDITIONAL COMPARISON, WHILE RECEIVING THE IVIG INFUSION WAS REPORTEDLY PERFORMED ON THE SAME PATIENT: CAPILLARY VALUE ON SUSPECT DEVICE WAS 24.4 MMOL/L, WHILE THE PLASMA VALUE MEASURED 10.4 MMOL/L. BASED ON THE FALSELY ELEVATED VALUES OBTAINED ON THE SUSPECT DEVICE, PATIENT WAS REPORTEDLY TREATED WITH INSULIN (AMOUNT AND TYPE NOT PROVIDED). PATIENT REPORTEDLY DEVELOPED HYPOGLYCEMIA DUE TO INSULIN ADMINISTRATION. NO DETAILS OF PATIENT'S SUBSEQUENT TREATMENT WERE PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACCU-CHEK ADVANTAGE TEST STRIPS BLOOD GLUCOSE TEST STRIPS NBW ROCHE DIAGNOSTICS NA UNK

Patients

Seq Age Sex Outcome Treatment
1 64 YR Required Intervention PREDNISONE| ACCU-CHEK ADVANTAGE BLOOD GLUCOSE MONITOR| INTRAGAM P| INSULIN